-
$ESPR was analyzed by 6. The buy percentage consensus is at 87. So analysts seem to be very confident about$ESPR. https://www.chartmill.com/stock/analyzer/stock/ESPR?view=analyst-ratings&utm_source=twitterUS&utm_medium=ANALYST&utm_content=ESPR&utm_campaign=social_tracking …pic.twitter.com/GFaTe8otrw
-
Covered
$ESPR (-3.4%). 132% long by 28% short. 33% long Technology, 32% long Health Care, 14% long Finance, 10% long Consumer Services. https://www.techtrader.ai/wall/?date=1580744928&post=11498&utm_medium=twitter&utm_campaign=techtraderai …#AI#AutonomousTradingpic.twitter.com/IukW1A9Y2G
-
$ESPR - Esperion: Recent Pullback Offers Buying Opportunity Ahead Of February PDUFA Dates. https://seekingalpha.com/article/4320656-esperion-recent-pullback-offers-buying-opportunity-ahead-of-february-pdufa-dates?source=tweet …https://seekingalpha.com/article/4320656-esperion-recent-pullback-offers-buying-opportunity-ahead-of-february-pdufa-dates … -
Chardan Capital Reaffirms Hold Rating for Esperion Therapeutics
$ESPR http://americanbankingnews.com/?p=13241970#stocks -
$ESPR: New SEC Filing for ESPR: Form 8-K (No. 0001104659-20-009245): http://stocknewsflow.com/1434868_000110465920009245_0001104659-20-009245 … -
European Advisory Group Backs Esperion's Cholesterol Drugs
@themotleyfool#stocks$ESPR https://www.fool.com/investing/2020/01/31/european-advisory-group-backs-esperions-cholestero.aspx … -
European advisory group backs Esperion combo tablet for high cholesterol
$ESPR https://newsfilter.io/articles/european-advisory-group-backs-esperion-combo-tablet-for-high-cholesterol-606b5429897525cabe7c2a8d0af65743 … -
The CHMP recommended granting marketing authorisations for Nilemdo (bempedoic acid) and Nustendi (bempedoic acid / ezetimibe) for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2020 …
$ESPR -
$ESPR Bemp approved by CHMP.$AGIO$CELG Idhifa for AML withdrawn https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2020 … -
$ESPR lots of volatility on no news? -
Esperion Therapeutics
$ESPR Shares Up 5.4% Following Insider Buying Activity http://zolmax.com/?p=3597921 -
-
$ESPR Is approval priced in?
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.